GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (NSE:ERIS) » Definitions » 3-Year Dividend Growth Rate

Eris Lifesciences (NSE:ERIS) 3-Year Dividend Growth Rate : 0.00% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences 3-Year Dividend Growth Rate?

Eris Lifesciences's Dividends per Share for the three months ended in Mar. 2024 was ₹0.00.

The historical rank and industry rank for Eris Lifesciences's 3-Year Dividend Growth Rate or its related term are showing as below:

During the past 12 years, the highest 3-Year average Dividends Per Share Growth Rate of Eris Lifesciences was 36.80% per year. The lowest was 36.80% per year. And the median was 36.80% per year.

NSE:ERIS's 3-Year Dividend Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 10.2
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

During the past 12 months, Eris Lifesciences's average Dividends Per Share Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Eris Lifesciences's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Eris Lifesciences's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Eris Lifesciences's 3-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Eris Lifesciences's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eris Lifesciences's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eris Lifesciences's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Eris Lifesciences's 3-Year Dividend Growth Rate falls into.



Eris Lifesciences 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Eris Lifesciences  (NSE:ERIS) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Eris Lifesciences's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 5.22
=0.00

During the past 12 years, the highest Dividend Payout Ratio of Eris Lifesciences was 0.26. The lowest was 0.14. And the median was 0.21.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 12 years, the highest Dividend Yield of Eris Lifesciences was 1.70%. The lowest was 0.52%. And the median was 0.89%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eris Lifesciences 3-Year Dividend Growth Rate Related Terms>


Eris Lifesciences (NSE:ERIS) Business Description

Traded in Other Exchanges
Address
Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (NSE:ERIS) Headlines

No Headlines